New York Life Trust’s Boston Scientific BSX Stock Holding History

New York Life Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,963	Closed	-$47K	–	218
2016 Q3	$47K	Buy	+1,963	New	+$46.8K	0.23%	133
2015 Q2	–	Sell	-779	Closed	-$14K	–	208
2015 Q1	$14K	Buy	+779	New	+$12.3K	0.06%	189
2014 Q1	–	Sell	-9,851	Closed	-$118K	–	203
2013 Q4	$118K	Buy	9,851 +19	+0.2%	+$224	0.54%	56
2013 Q3	$115K	Buy	9,832 +2,547	+35%	+$27.6K	0.58%	51
2013 Q2	$68K	Buy	+7,285	New	+$61.8K	0.31%	115

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

New York Life Trust's BSX Position: Q4 2016 in Review

New York Life Trust sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 1,963 shares — an estimated $47K sold.

New York Life Trust first reported a position in BSX in Q2 2013 and held it in 5 quarters. The position peaked at $118K in Q4 2013. 557 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

New York Life Trust reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
New York Life Trust sold 1,963 Boston Scientific shares in Q4 2016, an estimated $47K.
New York Life Trust first reported a position in Boston Scientific in Q2 2013 and held it in 5 quarters.
New York Life Trust's Boston Scientific position peaked at $118K in Q4 2013.
557 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on New York Life Trust's 13F filing for Q4 2016, filed 15 Feb 2017.